Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine- associated cardiotoxicity

WJ Crumb , B Wible, DJ Arnold, JP Payne and AM Brown

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

Use of the antihistamine terfenadine has been associated with QT prolongation and torsade de pointes. One possible mechanism is blockade of cardiac potassium channels. We therefore characterized the effects of terfenadine on potassium currents recorded from isolated human cardiac myocytes. We demonstrated terfenadine block of the transient outward current and a novel, ultra-rapidly activating, delayed rectifier K+ current (IKur), which is very sensitive to 4- aminopyridine. IKur is probably produced by the protein product of Kv1.5a, a Shaker-like potassium channel cDNA cloned from human heart. We also compared terfenadine blockade of fHK (Kv1.5a) currents stably expressed in a human embryonic kidney cell line with terfenadine blockade of IKur in human atrial myocytes. Using the patch-clamp technique, we found that terfenadine produced a time-dependent reduction in Kv1.5a current that was consistent with blockade from the cytoplasmic side of the channel. The terfenadine-sensitive Kv1.5a current in human embryonic kidney cells was similar to the 4- aminopyridine-sensitive current in human atrial myocytes. In addition to blockade of the transient outward current and IKur, terfenadine at clinically relevant concentrations blocked both the rapidly and slowly activating components of the delayed rectifier in human atrial myocytes. Blockade of these K+ currents may contribute to the cardiotoxicity associated with terfenadine usage.

Volume 47, Issue 1, pp. 181-190, 01/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. R. Gralinski The Dog's Role in the Preclinical Assessment of QT Interval Prolongation Toxicol Pathol, January 1, 2003; 31(1_suppl): 11 - 16. [Abstract] [PDF]

				J. Wang, K. Della Penna, H. Wang, J. Karczewski, T. M. Connolly, K. S. Koblan, P. B. Bennett, and J. J. Salata Functional and pharmacological properties of canine ERG potassium channels Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H256 - H267. [Abstract] [Full Text] [PDF]

				S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]

				E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF]

				M. Nishio, Y. Habuchi, H. Tanaka, J. Morikawa, T. Yamamoto, and K. Kashima Blockage by Terfenadine of the Adenosine Triphosphate (ATP)-Sensitive K+ Current in Rabbit Ventricular Myocytes J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 293 - 300. [Abstract] [Full Text]

				M. Taglialatela, A. Pannaccione, P. Castaldo, G. Giorgio, Z. Zhou, C. T. January, A. Genovese, G. Marone, and L. Annunziato Molecular Basis for the Lack of HERG K+ Channel Block-Related Cardiotoxicity by the H1 Receptor Blocker Cetirizine Compared with Other Second-Generation Antihistamines Mol. Pharmacol., July 1, 1998; 54(1): 113 - 121. [Abstract] [Full Text]

				C. M. Ko, I. Ducic, J. Fan, Y. M. Shuba, and M. Morad Suppression of Mammalian K+ Channel Family by Ebastine J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 233 - 244. [Abstract] [Full Text]

				M. D. Drici, T. R. Burklow, V. Haridasse, R. I. Glazer, and R. L. Woosley Sex Hormones Prolong the QT Interval and Downregulate Potassium Channel Expression in the Rabbit Heart Circulation, September 15, 1996; 94(6): 1471 - 1474. [Abstract] [Full Text]

				M. R. Rosen Of Oocytes and Runny Noses Circulation, August 15, 1996; 94(4): 607 - 609. [Full Text]

				M.-L. Roy, R. Dumaine, and A. M. Brown HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine Circulation, August 15, 1996; 94(4): 817 - 823. [Abstract] [Full Text]

				V. N. Uebele, S. K. England, A. Chaudhary, M. M. Tamkun, and D. J. Snyders Functional Differences in Kv1.5 Currents Expressed in Mammalian Cell Lines Are Due to the Presence of Endogenous Kvbeta2.1 Subunits J. Biol. Chem., February 2, 1996; 271(5): 2406 - 2412. [Abstract] [Full Text] [PDF]

				M.P. Davies, R.H. An, P. Doevendans, S. Kubalak, K.R. Chien, and R.S. Kass Developmental Changes in Ionic Channel Activity in the Embryonic Murine Heart Circ. Res., January 1, 1996; 78(1): 15 - 25. [Abstract] [Full Text]